Back to Journals » ClinicoEconomics and Outcomes Research » Volume 14

Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Singapore Healthcare System Perspective

Total article views   HTML views PDF downloads Totals
6,704 Dovepress* 6,035+ 370 6,405
PubMed Central* 669 185 854
Totals 6,704 555 7,259
*Since 3 May 2022
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar